← Back to All Filings

GH CMO Sells $73k in Shares for RSU Tax Withholding

Low SignificanceDecember 17, 2025 at 7:32:27 PM EST

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

GH CMO Sells $73k in Shares for RSU Tax Withholding

Company: Guardant Health, Inc. (GH) Form: 4 | Filed: 2025-12-17 Significance: Low

Insider: EAGLE CRAIG Title: Chief Medical Officer | Relationship: Officer

Transaction: • Type: Tax Withholding (Sell-to-Cover) • Shares: 711 • Price: $102.67 • Value: $72,998 • Owned After: 45,007

Key Insight: This is an automatic sale to cover tax obligations from vesting Restricted Stock Units (RSUs) and does not represent a discretionary trading decision by the insider.

Market Context: The transaction value represents a negligible percentage (<0.001%) of Guardant Health's $12.26B market capitalization.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Medical Officer of Guardant Health executed a routine, non-discretionary "sell-to-cover" transaction to satisfy tax liabilities arising from the vesting of Restricted Stock Units (RSUs).
  • Market Impact: Neutral. This type of transaction is common and does not typically influence market sentiment as it is not an indication of the insider's outlook on the company.

Company Information

FieldValue
CompanyGuardant Health, Inc.
Ticker SymbolGH
CIK0001576280
IndustryMedical Laboratories

Insider Information

FieldValue
NameEAGLE CRAIG
CIK0001562135
Title/PositionChief Medical Officer
RelationshipOfficer

Transaction Details

This filing reports the vesting of 1,402 RSUs (Code 'M') and a subsequent automatic disposition of shares to cover taxes (Code 'F'). The details below pertain to the tax-related sale.

FieldValue
Form Type4
Transaction Date2025-12-15
Transaction CodeF (Payment of tax liability by withholding securities)
Security TypeCommon Stock
Shares Involved711
Price Per Share$102.67
Total Value$72,998.37
Shares Owned After45,007
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$72,998.37
% of Market Cap<0.001%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction value is insignificant relative to Guardant Health's $12.26 billion market capitalization.
  • Transaction Significance: The sale is solely for tax purposes, as indicated by the 'F' transaction code and the accompanying footnote. Such transactions are pre-planned or automatic and carry low informational value for investors.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a non-discretionary sale to cover tax obligations from equity compensation. It does not reflect a change in the insider's confidence in the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The market generally understands that "sell-to-cover" transactions are not indicative of bearish sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing clearly indicates two related events: the acquisition of 1,402 shares upon vesting of RSUs (Code 'M') and the immediate disposition of 711 of those shares to cover taxes (Code 'F'). The net result was an increase in the insider's holdings of common stock.
Topics:#SECFiling#InsiderTrading#Form4#GH#GuardantHealth#RSUVesting#SellToCover#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.